About Aster Insights
Aster Insights is a Healthcare company based in Tampa (United States) founded in 2006. Contract-based oncology clinical trial services are provided by Aster Insights. Aster Insights has raised $75 million across 2 funding rounds from investors including McKesson, Hearst and The Ohio State University. Its chief executive, as recorded, is Jim Gabriele. Aster Insights offers products and services including ORIEN Network and Total Cancer Care. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is M2GEN, CORP. Its competitors include OnCusp, CancerVax and Oncotherapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Aster Insights was founded in 2006 and is headquartered in Tampa, United States. Operations focus on the healthcare sector, specifically oncology. Contract-based services for clinical trials are offered, including support for trial design, execution, and data management. Leadership is provided by CEO Jim Gabriele. The company serves clients in the pharmaceutical and biotechnology industries across the United States.
- Headquarters Tampa, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website asterinsights.com
- Social LinkedIn X YouTube
- Legal Name M2gen, Corp.
- Total Equity Funding$75M (USD)
in 2 rounds
- InvestorsMcKesson
& 6 more
Products & Services of Aster Insights
Aster Insights offers a comprehensive portfolio of products and services, including ORIEN Network and Total Cancer Care.
Facilitates oncology research collaborations and data exchange for product development.
Provides patient data for advancing cancer treatment and prevention strategies.
Apps and channels of Aster Insights
its YouTube channel Aster Insights has 10 subscribers and 11 videos.
Videos from Aster Insights
The most watched videos on Aster Insights's YouTube channel, Aster Insights (10 subscribers). Click a video to play it here.
More on Aster Insights.
Funding Insights of Aster Insights
Aster Insights has successfully raised a total of $75M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $75M
- Total Rounds 2
- First Round $75M
(Sep 2017)
- Investors Count 7
All 2 funding rounds of Aster Insights with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | Series C | – | Clayton Homes, Clayton Dubilier & Rice | ||
| Sep 2017 | $75M | Series B | – | Hearst | – |
7 investors in total: 7 institutional.
Investors in Aster Insights
Aster Insights has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include McKesson, Hearst and The Ohio State University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
Residential buildings are provided for purchase and rental options. | 1956 | claytonhomes.com | Knoxville, United States | |
A private equity firm focused on building long-term business value. | cdr-inc.com | New York, United States | ||
Products and services are provided in the healthcare industry. | 1833 | mckesson.com | Irving, United States | |
Oncology care is delivered via a network of specialized clinics. | 1986 | moffitt.org | United States | |
Multiple courses and degrees are offered across diversified academic streams. | 1870 | osu.edu | United States | |
Media conglomerate | 1887 | hearst.com | New York, United States |
Investor details for Aster Insights
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aster Insights
27 people are tracked at Aster Insights (13 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Jim Gabriele | CEO | Leadership |
Kim Morley | Executive Assistant To Chief Executive Officer/board Liaison | Leadership |
Xavier Avat | Executive Vice President, Chief Business Officer - Moffitt Cancer Center | Leadership |
Dave Schulte | Senior Vice President And Managing Director Of Mckesson Ventures | Leadership |
Phaedra Agius | Head Of Bioinformatics Research And Data Quality Analytics | Leadership |
Shane Huntsman | Senior Director, Clinical Integration & Informatics | Leadership |
Melissa Mitchell | Director, Strategic Alliances | Leadership |
Eric Rubin | Senior Vice President Of Global Clinical Oncology, Merck | Leadership |
Todd Johnson | Chief Growth Officer | Leadership |
David M. Rubin | Managing Director And Founding Partner, Merck Global Health Innovation Fund | Leadership |
Satya Mudiam | Director Of Data & ML Engineering | Leadership |
Xin Lu | Director, Data Science, Quality And Analytics | Leadership |
Michelle Churchman | Scientific Director | Leadership |
Michael D. Radmacher | Bioinformatics Research Scientist | Team |
Doug Lovvorn | Senior Systems Administrator | Team |
Jasmine Elliott | System Analyst | Team |
Mary Ellen Walker | Clinical Project Manager | Team |
Xingyan Kuang | Senior ML & NGS Engineer | Team |
Lauren Mayo Neal | Medical Informatics Manager | Team |
Cherie Creamer | Medical Information Specialist | Team |
7 more people are available in the full profile.
Complete people profiles for Aster Insights
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aster Insights
3 dated milestones of Aster Insights across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Aster Insights is founded.
- Funding First funding round of $75.0M.
- Funding Latest funding round, Series C,.
Competitors of Aster Insights
Aster Insights has 3 listed competitors in our database, 3 of them funded. They include OnCusp, CancerVax and Oncotherapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oncusptx.com | 2021 | New York, United States | $100M | CRO offering clinical development services for oncology drugs | ||
| cancervax.com | 1998 | Carlsbad, United States | $55M | Cancer vaccine research and development is conducted by CancerVax. | ||
| oncotherapeutics.com | 1988 | West Hollywood, United States | $8.3M | Preclinical and clinical oncology drug development services are provided. |
Detailed competitors of Aster Insights
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aster Insights (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aster Insights
Complete news archive for Aster Insights
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aster Insights
Aster Insights was founded in 2006 and raised its 1st funding round 11 years after it was founded.
Aster Insights is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Jim Gabriele is the CEO of Aster Insights, as recorded in our data.
Aster Insights is a funded company, having raised a total of $75M across 2 funding rounds to date. The company's 1st funding round was a Series B of $75M, raised on Sep 2017.
Aster Insights was founded in 2006 and is headquartered in Tampa, United States. Operations focus on the healthcare sector, specifically oncology. Contract-based services for clinical trials are offered, including support for trial design, execution, and data management. Leadership is provided by CEO Jim Gabriele. The company serves clients in the pharmaceutical and biotechnology industries across the United States.
Aster Insights's top competitors include CancerVax, OnCusp and Oncotherapeutics.
Aster Insights offers ORIEN Network and Total Cancer Care.
Aster Insights has 7 investors. Key investors include McKesson, Hearst, The Ohio State University, Moffitt Cancer Center, and Clayton Homes.
Aster Insights operates through M2gen, Corp..